SA
RARE icon

Sanctuary Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Sanctuary Advisors’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+6,204
New +$154K ﹤0.01% 2610

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Sanctuary Advisors's RARE Position: Q2 2026 in Review

Sanctuary Advisors opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 6,204 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #2610 among its holdings.

310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Sanctuary Advisors held 6,204 shares of Ultragenyx Pharmaceutical worth $207K as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new Sanctuary Advisors position in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2610 holding.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.